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Abstract: 31 
2 
 
Purpose: To quantify and identify microorganisms attached to the lumens and balloons 32 
of removed urethral urinary catheters and relate this to patient-specific information. 33 
 34 
Methodology: Indwelling urethral urinary catheters were collected from patients at a 35 
large teaching hospital in the UK. The balloon and lumen were separated, sonicated, and 36 
microorganisms were enumerated from the sonicate. Catheter specimen urine results 37 
were retrospectively reviewed. 38 
 39 
Results: Sixty-one catheters were analysed. The most commonly isolated organisms 40 
were Escherichia coli and Enterococcus faecalis. 19.7% of patients received antibiotics 41 
while catheterised and 25% of those had a multi-drug resistant (MDR) organism 42 
attached to the lumen. Conversely, only 2.04% of catheters from patients not known to 43 
be receiving antibiotics had a MDR organism present. All lumens were colonised 44 
irrespective of antibiotic use. Symptom presentation did not correlate with numbers of 45 
colonising organisms or species.  Despite heavy colonisation, only 8/61 patients were 46 
symptomatic.  47 
 48 
Conclusion: This study demonstrated that indwelling urinary catheters in place for 10 49 
days or greater were universally colonised and there was no correlation of colonisation 50 
with symptom presentation. Symptomatic presentation remains for the most important 51 
factor for defining CAUTI.  52 
 53 
 54 
 55 
 56 
 57 
Introduction: 58 
Infection is a well-recognised and costly complication of use of indwelling urinary 59 
catheters and is associated with increased mortality and increased length of hospital 60 
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stay(1, 2). The common causative agents of CAUTI reported in the USA  include 61 
Escherichia coli, Klebsiella pneumoniae, Enterococcus spp., Proteus mirabilis, 62 
Pseudomonas aeruginosa, Candida spp., and staphylococci(3) with approximately 20% 63 
of organisms isolated being multidrug-resistant (MDR)(4).  64 
However, there has been considerable confusion between symptomatic UTI 65 
(CAUTI) requiring antibiotic treatment and asymptomatic bacteriuria (CAASB) found 66 
commonly in catheterised patients but not requiring treatment. This has led to over-use 67 
of antibiotics with concomitant concern regarding resistance and adverse events (5). 68 
Most of the data on causative bacteria of both CAUTI and CAASB are derived from urine 69 
samples taken from the catheter (despite these being discouraged in catheterised 70 
patients) and little is known about the bacteria that colonise catheters(6). Though some 71 
authors have examined catheters, there has not, to our knowledge, been a systematic, 72 
quantitative study of the contents of removed urinary catheters. Therefore, this 73 
pragmatic study aims to quantify organisms attached the lumens and balloons of 74 
indwelling urethral urinary catheters and correlate this with patient data on antibiotic 75 
usage, symptom presentation, and catheter specimen urine (CSU) results.  76 
 77 
Methods: 78 
Setting and sample collection 79 
Between June 2015 and July 2016, indwelling urethral urinary catheters that 80 
remained in situ for ten days or greater from male and female patients over 16 years of 81 
age were collected from patients at Nottingham University Hospitals NHS Trust, 82 
Nottingham, UK. Catheters were collected from urology theatres, male urology ward, 83 
neurosurgery wards, and a neurorehabilitation centre by clinical staff when removed 84 
according to clinical need. Clinical staff were instructed to remove the catheter according 85 
to standard local protocols and if possible drain, but not flush, the lumen of any residual 86 
urine. Clinical staff were provided with an audit form to complete with patient details 87 
including the date the catheter was inserted, if the patient was prescribed antibiotics to 88 
their knowledge, and if they were symptomatic for CAUTI. Catheters were collected from 89 
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areas where experienced ward staff were familiar with CAUTI and its diagnosis. Local 90 
guidelines state antibiotics for CAUTI should be started immediately and the catheter 91 
changed during the treatment course, which is 7 days. The catheters were then placed in 92 
a resealable bag and stored in the specimen fridge (approx. +4°C) with information 93 
about antibiotics received and current symptoms of CAUTI. The catheters were analysed 94 
within 24 hours of removal. 95 
An audit to retrospectively review catheter specimen urine (CSU) results during 96 
the period of catheterisation of the patients who had catheters included in this study was 97 
approved by Nottingham University Hospitals NHS Trust (Audit ID: 17-309Q) in 98 
December 2017. The period of catheterisation was available in the notes and according 99 
to the audit form provided by the clinical staff. All CSU results from each patient’s period 100 
of catheterisation with the collected catheter were obtained retrospectively from 101 
microbiology reports available on a hospital-wide information system, NotIS (Nottingham 102 
Information System).  103 
 104 
Analysis of catheters 105 
The catheter was removed from the specimen bag using sterile forceps and 106 
placed onto a sheet of sterile autoclaved aluminium foil. Stainless steel, straight-jawed 107 
surgical clamps clamped the catheter on the lumen downstream of the balloon and on 108 
the lumen upstream of the drainage and balloon inflation ports. The balloon was then 109 
detached from the catheter body using a sterile scalpel and placed into a sterile universal 110 
container. Phosphate buffered saline (PBS, Oxoid, Basingstoke, UK) was added to the 111 
Universal container so that it covered the entire surface of the balloon section. The 112 
drainage and balloon inflation ports were separated from the catheter body and 113 
discarded. This left the lumen section with its ends clamped. Opening both ends of the 114 
clamps briefly, 1-2 mL PBS were introduced to fill the lumen depending on the size of the 115 
catheter. The ends were quickly reclamped and the catheter placed into a resealable 116 
freezer bag. 117 
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The balloon section and catheter lumen were sonicated for five minutes at 30 kHz 118 
to detach microorganisms. After sonication, both ends of the catheter body section were 119 
cleaned with an alcohol pre-injection swab (Mölnlycke Healthcare, Göteborg, Sweden). 120 
The lumen sonicate was drained into a sterile Bijou bottle (Sterilin, Newport, UK). 200μL 121 
of the balloon and lumen sonicates and appropriate dilutions were spread onto cysteine-122 
lactose electrolyte deficient (CLED) agar (Oxoid, Basingstoke, UK) and incubated 123 
overnight in air at 37°C. Colonies were enumerated and general microbiological 124 
identification performed, including use of the API identification system (bioMérieux, 125 
Marcy-l’Étoile, France) and MALDI-ToF (Microflex LT Mass Spectrometer, Bruker 126 
Daltronics). All isolates were tested for resistance according to EUCAST guidelines(7, 8). 127 
If culture negative, the plates were incubated for a further 24 hours.  128 
 129 
Statistics 130 
Data were analysed in GraphPad Prism 7.01 (La Jolla, California, USA). Normality was 131 
assessed by histogram, and some data not normally distributed were log-transformed. 132 
Correlation was assessed using the Pearson correlation. Significance was defined as 133 
p<0.05 and was calculated by unpaired t-test and one-way ANOVA depending on the 134 
number of comparisons. 135 
 136 
Results: 137 
Catheter Collection Demographics 138 
Sixty-one urethral urinary catheters were analysed. The mean age of patients 139 
from who the catheters were collected from was 68 years and 10/61 were female. The 140 
reasons for catheterisation were predominantly for management of urinary retention 141 
(64.62%), management of neurological or neurosurgical issues (21.31%), and 142 
transurethral resection of the prostate (16.39%), which correspond with specialties of 143 
the departments from which they originated. The types of catheters also varied with the 144 
majority being all-silicone for long-term use (50.8%), PTFE-coated (23.33%), all-silicone 145 
for short-term use (15.00%), latex (3.33%), hydrogel-coated latex (3.3.3%), and 146 
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hydrogel-coated silicone (3.33%). There was no significant difference in the quantity 147 
(p=0.4803, one-way ANOVA) of organisms attached to lumens of the different catheter 148 
types. However, there were more species of microorganisms per catheter attached to 149 
PTFE catheters than to all-silicone catheters (p=0.0073). The lumen sizes ranged from 150 
12Ch to 20Ch. 151 
 152 
Identification of microorganisms attached to the lumens and balloons 153 
107 and 103 organisms were isolated from the lumens and balloons, respectively, 154 
of 58 urinary catheters. Three lumens (4.9%) and three balloons (4.9%), not from the 155 
same catheter, were culture - negative. The same microorganisms were isolated from 156 
the lumen and the balloon of the same catheter in 65.6% of collected catheters.  The 157 
most commonly isolated organisms in both the balloons and lumens were E. coli and E. 158 
faecalis (Table I).  159 
 160 
Drug Resistance and Antibiotic Exposure 161 
Sixteen urinary catheters (26.2%) were from patients known to be receiving 162 
antibiotics and 12 of these were known to be receiving antibiotics for treatment of 163 
CAUTI, the other four receiving antibiotics prophylactically for other conditions and for 164 
treatment of other infections. Antibiotics prescribed for treatment of CAUTI included iv 165 
piperacillin-tazobactam, amoxicillin clavulanic acid, trimethoprim and pivmecillinam. 166 
Antibiotics for the four receiving antibiotics prophylactically and for other infections 167 
include iv piperacillin-tazobactam, amoxicillin clavulanic acid, vancomycin and 168 
meropenem. Of the 16 catheters from patients known to be receiving antibiotics, all 169 
lumens were colonised by at least one microorganism and 15/16 of the balloons were 170 
colonised. Antibiotics did not significantly reduce colonisation of catheter lumens 171 
(p=0.7153) or balloons (p=0.4516).  172 
Four multi-drug resistant organisms were isolated, including two extended-173 
spectrum beta-lactamases (ESBL)-producing E. coli and two meticillin-resistant S. 174 
epidermidis. MDR organisms were isolated from 25% of catheters from patients known 175 
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to be receiving antibiotics and from 2.04% of catheters from patients not known to be 176 
receiving antibiotics (p=0.0216, Fisher’s exact test). 177 
 178 
Length of catheterisation and colonisation of catheter lumens 179 
Information regarding the exact duration of catheterisation was available for 180 
48/61 catheters. There was no correlation between the duration of catheterisation and 181 
the number of microorganism species (Figure 1a) or the quantity of each microorganism 182 
(Figure 1b) in the lumen for catheters from patients symptomatic for CAUTI and 183 
asymptomatic. 8/61 patients were symptomatic for CAUTI (despite 12 being treated for 184 
CAUTI, only 8 had symptoms recorded) and length of catheterisation was available for 185 
7/8. There was no significant difference between the number of isolates (p=0.7741) or 186 
the quantity (CFU/mL) (p=0.0976) of microorganisms isolated from the lumens of 187 
catheters from symptomatic and asymptomatic patients underlining the importance of 188 
symptoms, not microbiological culture, in the diagnosis of CAUTI.  189 
 190 
CSU and Catheter Colonisation 191 
Three of the 61 patient notes were unavailable and were not included in this 192 
analysis. 28 CSU samples from 22 patients were taken during the period of 193 
catheterisation from which the catheter was collected and processed as standard by the 194 
microbiology department. Generally, there was a poor consensus between the laboratory 195 
CSU results and the organisms attached to the catheter lumens and balloons in that 196 
additional organisms (the majority of which were E. faecalis) were excluded from the 197 
reports despite catheter colonisation in significant numbers. Only 28.6% of the 198 
laboratory CSU reports matched the contents of the lumen and balloon. This suggests 199 
that CSU results do not reflect what is present on the catheter.  200 
 Antibiotic choice does not appear to be influenced by CSU results. Two of the 12 201 
patients prescribed antibiotics for CAUTI never had a CSU sent, and an additional 2/12 202 
had a CSU sent but the results were ‘no growth’. An additional patient was prescribed 203 
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cephalexin for an ESBL E. coli and another patient was prescribed pivmecillinam despite 204 
the results of a pivmecillinam resistant Proteus spp. in the report.  205 
 206 
Discussion: 207 
A novel method was developed for analysing the attached bacteria in the lumens 208 
and balloons separately without sampling the catheter external surface. The most 209 
commonly isolated organisms from the lumens and balloons of indwelling urinary 210 
catheters were Enterobacteriaceae and enterococci. Of interest, Proteus mirabilis is 211 
frequently cited (9) as a major problem in catheter users, but was isolated from only 212 
3/61 catheters collected, of which only two were blocked by mineral encrustations. In 213 
total, five catheters were blocked and E. coli and E. faecalis were the most common 214 
organisms isolated from the blocked catheter lumens, which is interesting as neither 215 
produces urease, which is cited as the cause of catheter blockage(10). 216 
60.7% of lumens and 57.4% of balloons were colonised by two or more 217 
organisms. This proportion is slightly lower than that found by Warren et al, who 218 
reported that 77% of their catheter urine specimens were polymicrobial, though they did 219 
not examine the catheters(11). 34.4% of the bladder contents as represented by the 220 
balloon isolates were different from those in the lumen. Additional organisms may be 221 
detected in catheter urine culture as these can be released into the passing urine, and 222 
culture results may adversely influence treatment. This can be seen from the lack of 223 
correlation between the catheter contents and the CSU results. This is in agreement with 224 
a study by Montgomerie et al who investigated the colonisation of the urethral meatus 225 
and urine cultures in those that perform intermittent catheterisation, and found that 226 
there was no correlation between urethral colonisation and urine samples (12). Quite 227 
often the lack of consistency comes from an additional organism not being recorded. For 228 
example, one catheter grew 107 and 106 CFU/mL E. coli and E. faecalis respectively from 229 
the catheter lumen and balloon, whereas only E. coli was recorded in the CSU report 230 
despite both present in large quantities. The patient was treated with iv piperacillin-231 
tazobactam when both isolates were sensitive to nitrofurantoin. Therefore, the 232 
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usefulness of CSUs is debatable given that they do not necessarily represent the 233 
microenvironment in the catheter lumen and more importantly, the catheter balloon, and 234 
do not appear to guide antibiotic prescribing. This then revisits the importance of 235 
symptom presentation as being the guiding factor for diagnosis and treatment of CAUTI. 236 
These data, which show no effect of antibiotics on the reduction of attached 237 
bacteria in the catheter, support the Scottish Intercollegiate Guidelines Network (13) and 238 
the Infectious Disease Society of America (14) recommendations for changing the 239 
catheter before starting antibiotic treatment for CAUTI. Antibiotics do not reduce 240 
attached biofilm bacteria and are likely to be a driver of antibiotic resistance. The higher 241 
proportion in this study of MDR isolates from catheters of patients receiving antibiotics 242 
may due to the influence of antibiotics, or it may be that MDR organisms more often 243 
cause symptoms and therefore require antibiotic treatment.  244 
 The relationship between the time the catheter remains in situ and increased rate 245 
of bacteriuria, incurring an increased risk of 5% per day, is well-established in the 246 
literature (15). From 10 days onwards, 96.7% of the catheter lumens and balloons were 247 
colonised in our study. There was no evidence of the number or quantity of species 248 
increasing from 10 days to 119 days, which was the longest duration of catheterisation 249 
in this study. It appears that by day 10, colonisation of the catheter may be established 250 
and thus there may not be capacity within the catheter to support additional 251 
microorganisms. In a study by Ganderton et al (16), there was no relationship between 252 
duration of catheterisation and amount of biofilm. In our study, there was also no 253 
difference between the number of species or the quantity of each isolate in those 254 
patients who were symptomatic and those who were asymptomatic. This again 255 
reinforces the emphasis for diagnosis to be placed on symptom presentation and not 256 
solely on the microbiological results, which may not accurately reflect the bladder 257 
contents as seen from the CSU results. 258 
 259 
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Figure legends: 328 
Figure 1: Correlation of A.) The number of isolates in each catheter lumen and B.) the 329 
quantity (CFU/mL) of each isolate in each catheter plotted against length of time the 330 
catheter was in situ. The Pearson correlation coefficient was computed and indicated no 331 
correlation of variables.  332 
 333 
Tables:  334 
Table I: Inventory of microorganisms isolated from the balloons and lumens of indwelling 335 
urethral urinary catheters in situ for 10 days or greater. 336 
Organisms isolated from catheter lumens 
 
Organisms isolated from catheter balloons 
Enterobacteriaceae 47 
 
Enterobacteriaceae 40 
Escherichia coli 24 
 
E. coli 20 
Klebsiella pneumoniae 5 
 
Klebsiella pneumoniae 5 
Enterobacter cloacae 4 
 
Enterobacter cloacae 4 
Klebsiella oxytoca 3 
 
Klebsiella oxytoca 3 
Proteus mirabilis 3 
 
Morganella morganii 2 
Morganella morganii 2 
 
Citrobacter koseri 1 
Serratia liquefaciens 2 
 
Citrobacter koseri/amalonaticus 1 
Hafnia alvei 1 
 
Hafnia alvei 1 
Pantoea spp. 1 
 
Pantoea spp. 1 
Citrobacter koseri 1 
 
Proteus mirabilis 1 
Citrobacter koseri/amalonaticus 1 
 
Serratia liquefaciens 1 
     
Enterococci 18 
 
Enterococci 20 
Enterococcus faecalis 17 
 
Enterococcus faecalis 19 
Enterococcus faecium 1 
 
Enterococcus faecium 1 
     
Pseudomonas spp.  16 
 
Pseudomonas spp.  12 
     
Staphylococci 14 
 
Staphylococci 19 
Staphylococcus epidermidis 4 
 
Staphylococcus epidermidis 9 
Staphylococcus aureus 3 
 
Staphylococcus aureus 3 
Staphylococcus capitis 2 
 
Staphylococcus caprae 2 
Staphylococcus haemolyticus 2 
 
Staphylococcus haemolyticus 2 
Staphylococcus caprae 1 
 
Staphylococcus xylosus 1 
Staphylococcus lugdunensis 1 
 
Staphylococcus hominis 1 
Staphylococcus saprophyticus 1 
 
Staphylococcus saprophyticus 1 
Staphylococcus xylosus 1 
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Yeasts 7 
Yeasts 6 
 
Candida albicans 4 
Candida albicans 4 
 
Candida glabrata 1 
Candida guilliermondii 1 
 
Candida guilliermondii 1 
Candida parapsilosis 1 
 
Candida parapsilosis 1 
     
Others 6 
 
Others 5 
Micrococcus spp. 2 
 
Streptococcus agalactiae 1 
Corynebacterium propinquum 1 
 
Streptococcus bovis 1 
Streptococcus agalactiae 1 
 
Streptococcus gordonii 1 
Streptococcus bovis 1 
 
Streptococcus intermedius 1 
Streptococcus intermedius 1 
 
Corynebacterium propinquum 1 
     
Total:  107 
 
Total: 103 
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